Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FP9H9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $94,178
Award facts
- Contract value 100% obligated
- $94,177.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $94,177.92 on August 18, 2025, for the supply of Dovato 50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract calls for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement that runs through December 2026 and authorizes the company to supply pharmaceutical products and medical supplies globally in support of military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive track record of supplying brand-name and generic medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical needs through competitively awarded arrangements, ranging from small-value transactions to substantial orders. This award reflects the company's role as a key vendor within the DLA's Medical Supply Chain, providing essential medications and medical commodities to support military personnel and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FP9H9?
SPE2DB25FP9H9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FP9H9 worth?
The government has obligated $94,178 on SPE2DB25FP9H9.
Is contract SPE2DB25FP9H9 an order under another contract?
Yes. SPE2DB25FP9H9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP9H9 competed?
The extent of competition for SPE2DB25FP9H9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award